We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$417M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$43.8M |
| 2 |
Gilead Sciences
GILD
|
+$40.8M |
| 3 |
GE Aerospace
GE
|
+$37.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$53.2M |
| 2 |
Amgen
AMGN
|
+$30.4M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$21.5M |
| 4 |
Canadian National Railway
CNI
|
+$20.9M |
| 5 |
Becton Dickinson
BDX
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.91% |
| 4 | Communication Services | 9.31% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
International Paper
IP
$22.3B
| $7.51M | 0.15% |
156,085
+97,056
| +164% | +$4.86M |
|
177
Union Pacific
UNP
$183B
| $7.41M | 0.14% |
69,910
+10,270
| +17% | +$1.1M |
|
178
Zions Bancorporation
ZION
$10.1B
| $7.33M | 0.14% |
174,537
-54,495
| -24% | -$2.37M |
|
|
SPLS
179
DELISTED
Staples Inc
SPLS
| $7.31M | 0.14% |
833,294
+803,038
| +2,654% | +$7.24M |
|
180
Royal Bank of Canada
RY
$291B
| $7.28M | 0.14% |
100,230
+6,577
| +7% | +$477K |
|
|
APC
181
DELISTED
Anadarko Petroleum
APC
| $7.27M | 0.14% |
117,275
+12,381
| +12% | +$824K |
|
182
Bio-Techne
TECH
$11.2B
| $7.27M | 0.14% |
286,000
+10,000
| +4% | +$258K |
|
183
Kinross Gold
KGC
$28.5B
| $7.24M | 0.14% |
2,059,382
+844,509
| +70% | +$3.03M |
|
184
Vulcan Materials
VMC
$36.3B
| $7.24M | 0.14% |
60,077
+40,200
| +202% | +$4.92M |
|
185
CVS Health
CVS
$137B
| $7.23M | 0.14% |
92,139
+14,012
| +18% | +$1.12M |
|
|
YHOO
186
DELISTED
Yahoo Inc
YHOO
| $7.13M | 0.14% |
153,520
+12,351
| +9% | +$551K |
|
187
Manulife Financial
MFC
$72.6B
| $7.11M | 0.14% |
401,647
-282,711
| -41% | -$5.21M |
|
188
Capri Holdings
CPRI
$1.77B
| $7.06M | 0.14% |
185,271
+164,303
| +784% | +$6.47M |
|
189
Toronto Dominion Bank
TD
$198B
| $7.01M | 0.14% |
140,352
+14,430
| +11% | +$737K |
|
|
WRK
190
DELISTED
WestRock Company
WRK
| $6.92M | 0.13% |
133,008
-6,968
| -5% | -$368K |
|
191
Edison International
EIX
$30.7B
| $6.82M | 0.13% |
85,683
+68,480
| +398% | +$5.19M |
|
192
General Motors
GM
$74.7B
| $6.75M | 0.13% |
190,770
+123,285
| +183% | +$4.51M |
|
193
Duke Energy
DUK
$102B
| $6.69M | 0.13% |
81,572
+46,709
| +134% | +$3.71M |
|
194
Cooper Companies
COO
$13.7B
| $6.68M | 0.13% |
+133,696
| New | +$6.35M |
|
195
Occidental Petroleum
OXY
$57B
| $6.68M | 0.13% |
105,421
+17,427
| +20% | +$1.16M |
|
196
Mondelez International
MDLZ
$77.7B
| $6.51M | 0.13% |
151,169
+12,841
| +9% | +$569K |
|
197
Elevance Health
ELV
$81.9B
| $6.41M | 0.12% |
38,773
-15,150
| -28% | -$2.41M |
|
|
POT
198
DELISTED
Potash Corp Of Saskatchewan
POT
| $6.41M | 0.12% |
375,202
+91,574
| +32% | +$1.66M |
|
199
Costco
COST
$415B
| $6.4M | 0.12% |
38,169
+7,505
| +24% | +$1.26M |
|
200
NetApp
NTAP
$32.9B
| $6.38M | 0.12% |
152,561
+8,295
| +6% | +$327K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2017 Portfolio in Review
As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.
- Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
- Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
- Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
- Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
- Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
- Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.
Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.